期刊文献+

全外显子测序在乳腺癌发病机制及诊疗中的研究进展 被引量:3

Progress of Whole Exon Sequencing in Pathogenesis and Diagnosis of Breast Cancer
下载PDF
导出
摘要 全外显子测序是利用序列捕获技术将全基因组外显子区域DNA捕捉并富集后进行高通量测序的基因组分析方法,该技术已经应用到各种复杂疾病的基因诊疗中。目前,乳腺癌的发病机制尚未完全阐明,而体细胞基因突变造成的癌基因激活与抑癌基因失活在乳腺癌发生发展的过程中扮演着至关重要的作用。近年来,众多研究小组开展了大量的全外显子测序研究,发现并鉴定了许多与复杂疾病/性状相关联的遗传变异,为复杂疾病包括乳腺癌的发病机制研究提供了重要线索。本文就全外显子测序在乳腺癌的发病机制及其诊治研究进行综述。 Whole exon sequencing is a genomic analysis method that uses sequence capture technology to capture and enrich the whole genome exon region DNA for high-throughput sequencing. This technology has been applied to gene diagnosis and treatment of various complex diseases. At present, the pathogenesis of breast cancer has not been clearly elucidated, and the activation of oncogenes and the inactivation of tumor suppressor genes caused by gene mutation of somatic cells play a crucial role in the development of breast cancer. In recent years, numerous research groups have carried out a large number of whole exon sequencing researches, found and identified many genetic mutations associated with complex diseases/traits,which provide important clues for the study of the pathogenesis of complex diseases. This paper reviews the pathogenesis and diagnosis and treatment of breast cancer by whole exon sequencing.
作者 金卫华 张瑞涛 JIN Weihua;ZHANG Ruitao(Department of Anatomy and Tissue Embryology, Medical College of China Three Gorges University, Yichang 443000, China;Department of Basic Medicine, Medical College of Hubei Three Gorges Polytechnic, Yichang 443000, China Corresponding)
出处 《肿瘤防治研究》 CAS CSCD 2019年第5期482-485,共4页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金(81202565) 湖北省教育厅重点项目(D20171205)
关键词 全外显子测序 乳腺癌 发病机制 诊断 治疗 Whole exon sequencing Breast cancer Pathogenesis Diagnosis Treatment
  • 引文网络
  • 相关文献

参考文献1

二级参考文献13

  • 1全国肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究(1990-1992)[M].北京:人民卫生出版社,2008.82-101.
  • 2Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
  • 3De Santis C,Ma J,Bryan L,et al.Breast cancer statistics,2013[J].CA Cancer J Clin,2014,64(1):52-62.
  • 4De Santis C,Siegel R,Bandi P,et al.Breast cancer statistics,2011[J].CA Cancer J Clin,2011,61(6):409-418.
  • 5Mettlin C.Global breast cancer mortality statistics[J].CA Cancer J Clin,1999,49(3):138-144.
  • 6Zeng H,Zheng R,Guo Y,et al.Cancer survival in China,2003-2005:a population-based study[J].Int J Cancer,2015,136(8):1921-1930.
  • 7Zeng H,Zheng R,Zhang S,et al.Female breast cancer statistics of 2010 in China:estimates based on data from 145 populationbased cancer registries[J].J Thorac Dis,2014,6(5):466-470.
  • 8Allemani C,Sant M,Weir HK,et al.Breast cancer survival in the US and Europe:a CONCORD high-resolution study[J].Int J Cancer,2013,132(5):1170-1181.
  • 9Walters S,Maringe C,Butler J,et al.Breast cancer survival and stage at diagnosis in Australia,Canada,Denmark,Norway,Sweden and the UK,2000-2007:a population-based study[J].Br J Cancer,2013,108(5):1195-1208.
  • 10Li N,Zheng RS,Zhang SW,et al.Analysis and prediction of breast cancer incidence trend in China[J].Chin J Prev Med,2012,46(8):703-707.

共引文献874

同被引文献44

引证文献3

二级引证文献15

;
使用帮助 返回顶部